Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125567762 | 12556776 | 2 | F | 20160705 | 20160802 | 20160714 | 20160810 | EXP | US-ASTRAZENECA-2016SE74162 | ASTRAZENECA | 22640.00 | DY | F | Y | 49.90000 | KG | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125567762 | 12556776 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | N | U | 206995 | 250 | MG | TABLET | QD | |||||
| 125567762 | 12556776 | 2 | SS | IRESSA | GEFITINIB | 1 | Oral | N | U | 206995 | 250 | MG | TABLET | QD | |||||
| 125567762 | 12556776 | 3 | SS | IRESSA | GEFITINIB | 1 | Oral | N | U | 206995 | 250 | MG | TABLET | QD | |||||
| 125567762 | 12556776 | 4 | C | TARCEVA | ERLOTINIB HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125567762 | 12556776 | 5 | C | OTHER | UNSPECIFIED INGREDIENT | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125567762 | 12556776 | 1 | Lung carcinoma cell type unspecified stage IV |
| 125567762 | 12556776 | 2 | Lung carcinoma cell type unspecified stage IV |
| 125567762 | 12556776 | 3 | Lung carcinoma cell type unspecified stage IV |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125567762 | 12556776 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125567762 | 12556776 | Blister | |
| 125567762 | 12556776 | Drug dose omission | |
| 125567762 | 12556776 | Haemolytic anaemia | |
| 125567762 | 12556776 | Infection | |
| 125567762 | 12556776 | Pruritus | |
| 125567762 | 12556776 | Rash generalised | |
| 125567762 | 12556776 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125567762 | 12556776 | 1 | 201607 | 0 | ||
| 125567762 | 12556776 | 3 | 20160614 | 0 |